A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
Phase 3
18+
36 sites in CA, CO, FL +10
What this study is about
This Phase 3 study is focused on people with obesity. The primary outcome being measured is Percent Change from baseline in body weight.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Percent Change from baseline in body weight
Secondary: Change from Baseline in Control of Eating Questionnaire (CoEQ), Change from Baseline in Diastolic Blood Pressure (DBP), Change from Baseline in EuroQoL 5-Dimension 5-Level (EQ5D-5L), Change from Baseline in Fasting Glucose, Change from Baseline in Fasting insulin, Change from Baseline in Food Noise Questionnaire (FNQ), Change from baseline in Fasting triglycerides, Change from baseline in High-density lipoprotein cholesterol
Endocrinology